Tumor-suppressive microRNAs in lung cancer: Diagnostic and therapeutic opportunities

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 626-628

  Sempere, Lorenzo F ^a   Liu, Xi ^a   Dmitrovsky, Ethan ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cyclin E; Expression profiling; In situ hybridization; Lung cancer; microRNA (miRNA, miR); miR 142 5p; miR 34c; miR145

Indexed keywords

ANTI MIR 122; ANTINEOPLASTIC AGENT; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; K RAS PROTEIN; LOCKED NUCLEIC ACID; MICRORNA; MIR 142 5P; MIR 145; MIR 34A; MIR 34B; MIR 34C; MYC PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER PATIENT; CELL CYCLE PROGRESSION; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; IN SITU HYBRIDIZATION; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; ONCOGENE C MYC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; GENETICS; LUNG TUMOR; METABOLISM; MOUSE;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICRORNAS;

EID: 70349303891     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.88     Document Type: Article

References (12)

1. http://www.cancer.gov/cancertopics/types/lung
2. Liu, X., Sempere, L.F., Galimberti, F., Freemantle, S.J., Black, C., Dragnev, K.H., Ma, Y., Fiering, S., Memoli, V., Li, H., DiRenzo, J., Korc, M., Cole, C.N., Bak, M., Kauppinen, S., and Dmitrovsky, E. (2009) Uncovering growthsuppressive microRNAs in lung cancer. Clin. Cancer Res. 15, 1177-1183.
3. Carthew, R.W. and Sontheimer, E.J. (2009) Origins and mechanisms of miRNAs and siRNAs. Cell 136, 642-655.
4. Barbarotto, E., Schmittgen, T.D., and Calin, G.A. (2008) MicroRNAs and cancer: profile, profile, profile. Int. J. Cancer 122, 969-977.
5. Ventura, A. and Jacks, T. (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586-591.
6. Ma, Y., Fiering, S., Black, C., Liu, X., Yuan, Z., Memoli, V.A., Robbins, D.J., Bentley, H.A., Tsongalis, G.J., Demidenko, E., Freemantle, S.J., and Dmitrovsky, E. (2007) Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc. Natl. Acad. Sci. U. S. A. 104, 4089-4094. (Pubitemid 47181583)
7. Kauppinen, S., Vester, B., and Wengel, J. (2006) Locked nucleic acid: high-affinity targeting of complementary RNA for RNomics. Handb. Exp. Pharmacol. (173), 405-422.
8. Sempere, L.F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C.V., Schwartz, G., Wells, W., Kauppinen, S., and Cole, C.N. (2007) Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 67, 11612-11620.
9. He, L., He, X., Lowe, S.W., and Hannon, G.J. (2007) microRNAs join the p53 network--another piece in the tumoursuppression puzzle. Nat. Rev. Cancer 7, 819-822. (Pubitemid 350006254)
10. Kumar, M.S., Erkeland, S.J., Pester, R.E., Chen, C.Y., Ebert, M.S., Sharp, P.A., and Jacks, T. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. U. S. A. 105, 3903-3908.
11. Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., Elble, R., Watabe, K., and Mo, Y.Y. (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. U. S. A. 106, 3207-3212.
12. Petri, A., Lindow, M., and Kauppinen, S. (2009) MicroRNA silencing in primates: towards development of novel therapeutics. Cancer Res. 69, 393-395.